TheraCell is a leading biotechnology company based in Greece, established in 2013. It specializes in the development of innovative cellular and gene therapy products and is involved in the commercialization of a diverse pipeline of cell and gene therapies. As a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), TheraCell provides essential services to the pharmaceutical industry, focusing on the enhancement and delivery of advanced therapeutic solutions.

Services include:
– Cell therapy development
– Gene therapy development
– Process development
– Quality assurance and control
– Regulatory support
– Scale-up and production
– Packaging and logistics

TheraCell is committed to advancing the field of biotechnology through its extensive expertise and comprehensive service offerings. For more information, please visit theracell.eu.